Home Biosimilar Antibodies Immunology & Inflammation Interleukins antibody Vunakizumab (Anti-CTLA-8 / IL-17a) For research use only.
Not for use in humans.

Vunakizumab (Anti-CTLA-8 / IL-17a)

Synonyms:

Vunakizumab (Anti-CTLA-8 / IL-17a) is a recombinant human IgGκ monoclonal antibody that targets interleukin-17A (IL-17A) and inhibits its interaction with the IL-17 receptor. Vunakizumab can be used to study autoimmune diseases such as psoriatic arthritis, ankylosing spondylitis, multiple sclerosis, and inflammatory arthritis. MW: 146.28.

Vunakizumab (Anti-CTLA-8 / IL-17a)

Purity & Quality Control

≥99

Choose Selective Interleukins Inhibitors

Biological Activity

Description Vunakizumab (Anti-CTLA-8 / IL-17a) is a recombinant human IgGκ monoclonal antibody that targets interleukin-17A (IL-17A) and inhibits its interaction with the IL-17 receptor. Vunakizumab can be used to study autoimmune diseases such as psoriatic arthritis, ankylosing spondylitis, multiple sclerosis, and inflammatory arthritis. MW: 146.28.

Product Details

CAS No. 1792181-33-9
Molecular Weight 146.28
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Vunakizumab (Anti-CTLA-8 / IL-17a) | Vunakizumab (Anti-CTLA-8 / IL-17a) supplier | purchase Vunakizumab (Anti-CTLA-8 / IL-17a) | Vunakizumab (Anti-CTLA-8 / IL-17a) cost | Vunakizumab (Anti-CTLA-8 / IL-17a) manufacturer | order Vunakizumab (Anti-CTLA-8 / IL-17a) | Vunakizumab (Anti-CTLA-8 / IL-17a) distributor